Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis. Issue 9 (29th August 2019)
- Record Type:
- Journal Article
- Title:
- Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis. Issue 9 (29th August 2019)
- Main Title:
- Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis
- Authors:
- Ruffenach, Gregoire
Umar, Soban
Vaillancourt, Mylene
Hong, Jason
Cao, Nancy
Sarji, Shervin
Moazeni, Shayan
Cunningham, Christine M
Ardehali, Abbas
Reddy, Srinivasa T
Saggar, Rajan
Fishbein, Gregory
Eghbali, Mansoureh - Abstract:
- Abstract: Pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) is one of the most common causes of PH, and there is no approved therapy. The molecular signature of PF‐PH and underlying mechanism of why pulmonary hypertension (PH) develops in PF patients remains understudied and poorly understood. We observed significantly increased vascular wall thickness in both fibrotic and non‐fibrotic areas of PF‐PH patient lungs compared to PF patients. The increased vascular wall thickness in PF‐PH patients is concomitant with a significantly increased expression of the transcription factor Slug within the macrophages and its target prolactin‐induced protein (PIP), an extracellular matrix protein that induces pulmonary arterial smooth muscle cell proliferation. We developed a novel translational rat model of combined PF‐PH that is reproducible and shares similar histological features (fibrosis, pulmonary vascular remodeling) and molecular features (Slug and PIP upregulation) with human PF‐PH. We found Slug inhibition decreases PH severity in our animal model of PF‐PH. Our study highlights the role of Slug/PIP axis in PF‐PH. Synopsis: Pulmonary hypertension (PH) is a major complication of pulmonary fibrosis (PF), yet it is poorly understood. This study highlights the Slug/PIP axis as a key driver of vascular remodeling in pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) patients. Vascular walls were thickened in both fibrotic and non‐fibrotic areas in the lungsAbstract: Pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) is one of the most common causes of PH, and there is no approved therapy. The molecular signature of PF‐PH and underlying mechanism of why pulmonary hypertension (PH) develops in PF patients remains understudied and poorly understood. We observed significantly increased vascular wall thickness in both fibrotic and non‐fibrotic areas of PF‐PH patient lungs compared to PF patients. The increased vascular wall thickness in PF‐PH patients is concomitant with a significantly increased expression of the transcription factor Slug within the macrophages and its target prolactin‐induced protein (PIP), an extracellular matrix protein that induces pulmonary arterial smooth muscle cell proliferation. We developed a novel translational rat model of combined PF‐PH that is reproducible and shares similar histological features (fibrosis, pulmonary vascular remodeling) and molecular features (Slug and PIP upregulation) with human PF‐PH. We found Slug inhibition decreases PH severity in our animal model of PF‐PH. Our study highlights the role of Slug/PIP axis in PF‐PH. Synopsis: Pulmonary hypertension (PH) is a major complication of pulmonary fibrosis (PF), yet it is poorly understood. This study highlights the Slug/PIP axis as a key driver of vascular remodeling in pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) patients. Vascular walls were thickened in both fibrotic and non‐fibrotic areas in the lungs of PF‐PH patients, but wall thickening was mainly restricted to fibrotic areas of PF patients. In PF‐PH patients, the transcriptional factor Slug was up‐regulated in macrophages and led to increased vascular wall thickness through its target PIP. Inhibition of Slug ameliorated PH in an animal model that recapitulates human histological and molecular characteristics of PF‐PH. Abstract : Pulmonary hypertension (PH) is a major complication of pulmonary fibrosis (PF), yet it is poorly understood. This study highlights the Slug/PIP axis as a key driver of vascular remodeling in pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) patients. … (more)
- Is Part Of:
- EMBO molecular medicine. Volume 11:Issue 9(2019)
- Journal:
- EMBO molecular medicine
- Issue:
- Volume 11:Issue 9(2019)
- Issue Display:
- Volume 11, Issue 9 (2019)
- Year:
- 2019
- Volume:
- 11
- Issue:
- 9
- Issue Sort Value:
- 2019-0011-0009-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2019-08-29
- Subjects:
- non‐fibrotic area -- prolactin‐induced protein -- Slug -- vascular remodeling
Molecular biology -- Periodicals
Medical genetics -- Periodicals
Pathology, Molecular -- Periodicals
616.04205 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1757-4684 ↗
http://www3.interscience.wiley.com/journal/120756871/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.15252/emmm.201810061 ↗
- Languages:
- English
- ISSNs:
- 1757-4676
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11675.xml